Company / Operating Income per Share
Eton Pharmaceuticals, Inc. Operating Income per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.05
FY2025
5-year range
-$1.10 / -$0.05
FY2021-FY2025
Trend
+85.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 7 years, ranging from $-1.10 in FY2022 to $-0.05 in FY2025.
Based on SEC 10-K filings.
-0.05 in FY2025.
Improved from $-0.06 to $-0.05 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 85.8% year-over-year.
- Lowest operating income per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.05 | +85.8% |
| FY2024 | -$0.33 | -429.8% |
| FY2023 | -$0.06 | +94.4% |
| FY2022 | -$1.10 | -43.9% |
| FY2021 | -$0.77 | -32.5% |
| FY2020 | -$0.58 | -42.2% |
| FY2019 | -$0.41 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026